← Leaderboards
Christian Bime
Johns Hopkins University
$1,645,419
Attributed
$1,779,501
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $702K · FY2010–23$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,779,501 · 5
By mechanism
K08$863,460 · 1
R56$529,354 · 1
UH3$153,040 · 1
F32$118,522 · 1
R21$115,125 · 1
Top collaborators
- Joe G. N. Garcia1 shared
- Natalia A Ignatenko1 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Ashraf Fawzy$1,367,068
- Robert A. Wise$33,179,807
- Theresa A Shapiro$12,921,052
- Sufey Ong$84,464
- David Hughes$91,052
Others in their field
Top investigators on “Inflammatory”
- David Heimbrook · Leidos Biomedical Research, Inc.$85,243,263
- Edward A Dennis · University Of California, San Diego$72,701,136
- Constance Ann Benson · University Of California, San Diego$65,790,143
- Randall J Bateman · Washington University$62,939,456
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Keri Hammel · The Emmes Company, Llc$53,700,408
Research focus
InflammatoryInflammationSeveritiesGenesProteinsLung InjuryP-SelectinP-Selectin Ligand ProteinPre-ClinicalPhenotypeLigandsLeadDesignLungPredispositionGene ExpressionMouse ModelInsightGenetic VariantGeneticMortalityHealth DisparityIn VivoPathway Interactions
Grant awards (10)
Targeting polyamines to suppress SARS-CoV-2 related disease$153,040
UH3 · FY2023 · TR
Validation of a Genetic-based Biomarker Panel for Stratification of Mortality Risk in ARDS Patients$115,125
R21 · FY2023 · HL · contact PI
Increasing the Success of ARDS Therapeutic Clinical Trials: Novel Trial Design and Targeting of the P-selectin Pathway$529,354
R56 · FY2022 · HL · contact PI
SELPLG as a candidate gene in Acute Respiratory Distress Syndrome$172,692
K08 · FY2022 · HL · contact PI
SELPLG as a candidate gene in Acute Respiratory Distress Syndrome$172,692
K08 · FY2021 · HL · contact PI
SELPLG as a candidate gene in Acute Respiratory Distress Syndrome$172,692
K08 · FY2020 · HL · contact PI
SELPLG as a candidate gene in Acute Respiratory Distress Syndrome$172,692
K08 · FY2019 · HL · contact PI
SELPLG as a candidate gene in Acute Respiratory Distress Syndrome$172,692
K08 · FY2018 · HL · contact PI
Study of Asthma and Nasal Steroids Trial-An ancillary mechanistic study$58,604
F32 · FY2011 · AI · contact PI
Study of Asthma and Nasal Steroids Trial-An ancillary mechanistic study$59,918
F32 · FY2010 · AI · contact PI